Wilson Sonsini Goodrich & Rosati represented Circle Pharma in the transaction.Circle Pharma, a clinical-stage biopharmaceutical company, announced the closing of a $90 million Series D financing…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
